NAGE Stock Analysis: Buy, Sell, or Hold?
NAGE - Niagen Bioscience, Inc. Common Stock
$4.17
-0.02 (-0.48%)
▼
5d:
-14.02%
30d:
-6.92%
90d:
-19.81%
WAIT
LOW Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 13, 2026
2d
Smart Money Accumulation
NAGE is down 14.0% this week, but smart money is accumulating calls. Top strike: $5 2026-06-18 with 43 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When NAGE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NAGE is down 14.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: NAGE is down 14.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$12.96
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$8.05
48.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NAGE is currently trading at $4.17, which is considered oversold relative to its 30-day fair value range of $4.43 to $4.90. From a valuation perspective, the stock is trading at a discount (Forward PE: 13.0) compared to its historical average (20.8). Remarkably, the market is currently pricing in an annual earnings decline of 14.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NAGE is in a strong downtrend. Immediate support is located at $4.04, while resistance sits at $5.12.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.00 (+211.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NAGE is in a strong downtrend. Immediate support is located at $4.04, while resistance sits at $5.12.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.00 (+211.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.43 -
$4.90
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Protect Your Profits
Holding NAGE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 211.8% below Wall St target ($13.00)
- WARNING: Recommendation downgraded due to -14.0% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$4.43 -
$4.90
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$4.04
Resistance Level
$5.12
Current Trend
Strong Downtrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.03
Wall Street Target
$13.00
(+211.8%)
Revenue Growth (YoY)
16.2%
Earnings Growth (YoY)
-41.6%
Profit Margin
13.4%
Valuation Discount vs History
-14.5% cheaper
PE vs Historical
13.0 vs 20.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-14.5%
(market-implied from PE analysis)
1-Year Target
$3.75
(-10%)
2-Year Target
$3.38
(-19%)
3-Year Target
$3.04
(-27%)
3-Yr Target (if PE normalizes)
(PE: 13→21)
$4.85
(+16%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.9, Growth: 33.3%)
$16.64
(+299%)
Base:
(SPY PE: 13.0, Growth: 33.3%)
$9.88
(+137%)
Bear:
(PE: 11.1, Growth: 33.3%)
$8.40
(+102%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (20x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Trailing PE: 19.95 | Current EPS (TTM): $0.21
Bull Case
$7.02
(+68%)
Analyst growth 52.4%, PE expands to 22.0
Base Case
$6.38
(+53%)
Market implied 52.4%, PE stable at 20.0
Bear Case
$2.85
(-32%)
Severe decline -20.0%, PE contracts to 17.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.0 to 20.8
Stabilization Target:
$6.66
(+59.6%)
PE Expansion Potential:
+59.6%
Share & Embed Analysis
Last updated: May 10, 2026 3:39 PM ET
Data refreshes hourly during market hours. Next update: 4:39 PM
Data refreshes hourly during market hours. Next update: 4:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NAGE showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Ozan Pamir
BUY
4465 shares
2025-11-14
Ozan Pamir
BUY
2220 shares
2025-11-14
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 69 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$104 | 61 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 58 HOLD |
|
VYGR
Voyager Therapeutics Inc |
STRONG BUY
12 analysts |
$15 | 58 HOLD |
Advanced NAGE Option Strategies
Professional options setups generated by AI based on today's NAGE price and gamma walls.
